Patient Square Capital LP
An institutional investment manager in MENLO PARK, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 12, 2026. SEC CIK 1819257.
- Reported value$645.5m
- Positions23
Holdings: 23 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd | SHS | G76279101 | 284 | 44.0% | 8,020,928 | Reduced−145,119 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 51.7 | 8.0% | 276,000 | New+276,000 | |
| Mirum Pharmaceuticals IncMIRM | COM | 604749101 | 30.5 | 4.7% | 260,500 | Added+30,500 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 27.5 | 4.3% | 206,500 | Added+85,255 | |
| Beone Medicines LtdONC | SPONSORED ADS | 07725L102 | 25.7 | 4.0% | 90,020 | Added+9,478 | |
| Pharvaris N V | COM | N69605108 | 23.2 | 3.6% | 671,209 | Added+178,209 | |
| Argenx SEARGX | SPONSORED ADR | 04016X101 | 21.3 | 3.3% | 23,000 | Reduced−13,718 | |
| United Therapeutics Corp DelUTHR | COM | 91307C102 | 20.1 | 3.1% | 37,120 | New+37,120 | |
| Belite Bio IncBLTE | SPONSORED ADS | 07782B104 | 16.9 | 2.6% | 110,000 | Reduced−6,684 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 16.4 | 2.5% | 425,000 | Reduced−171,000 | |
| DBV Technologies S aDBVT | SPONSORED ADS | 23306J309 | 14.9 | 2.3% | 909,474 | Added+215,940 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 13.3 | 2.1% | 220,000 | Reduced−7,000 | |
| Biontech SEBNTX | SPONSORED ADS | 09075V102 | 12.5 | 1.9% | 134,429 | New+134,429 | |
| Arcus Biosciences IncRCUS | COM | 03969F109 | 11.0 | 1.7% | 355,800 | Added+160,800 | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 10.8 | 1.7% | 212,500 | Added+12,500 | |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 10.5 | 1.6% | 108,000 | Added+14,118 | |
| Allogene Therapeutics IncALLO | COM | 019770106 | 10.5 | 1.6% | 5,050,000 | Added+1,600,000 | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 10.3 | 1.6% | 720,000 | Reduced−75,000 | |
| Arcutis Biotherapeutics IncARQT | COM | 03969K108 | 9.7 | 1.5% | 370,000 | Reduced−30,645 | |
| C4 Therapeutics IncCCCC | COM STK | 12529R107 | 7.5 | 1.2% | 1,608,815 | New+1,608,815 | |
| Inventiva SAIVA | ADS | 46124U107 | 7.4 | 1.2% | 1,967,171 | New+1,967,171 | |
| Kymera Therapeutics IncKYMR | COM | 501575104 | 5.4 | 0.8% | 47,500 | Reduced−52,500 | |
| Faeth Therapeutics IncFTH | COM NEW | 81728A207 | 4.4 | 0.7% | 175,050 | New+175,050 |
Sold out: 12 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Assembly Biosciences IncASMB | COM NEW | 045396207 | 0.0 | 0.0% | 0 | Sold out−136,315 | |
| Celcuity IncCELC | COM | 15102K100 | 0.0 | 0.0% | 0 | Sold out−95,000 | |
| Cytomx Therapeutics Inc.CTMX | COM | 23284F105 | 0.0 | 0.0% | 0 | Sold out−1,085,790 | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 0.0 | 0.0% | 0 | Sold out−331,000 | |
| Harrow IncHROW | COM | 415858109 | 0.0 | 0.0% | 0 | Sold out−165,209 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 0.0 | 0.0% | 0 | Sold out−157,500 | |
| Legend Biotech CorpLEGN | SPONSORED ADS | 52490G102 | 0.0 | 0.0% | 0 | Sold out−990,000 | |
| Merck & Co IncMRK | COM | 58933Y105 | 0.0 | 0.0% | 0 | Sold out−80,000 | |
| Nektar TherapeuticsNKTR | COM NEW | 640268306 | 0.0 | 0.0% | 0 | Sold out−210,000 | |
| Perspective Therapeutics IncCATX | COM NEW | 46489V302 | 0.0 | 0.0% | 0 | Sold out−1,625,000 | |
| Protara Therapeutics IncTARA | COM STK | 74365U107 | 0.0 | 0.0% | 0 | Sold out−1,030,846 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 0.0 | 0.0% | 0 | Sold out−1,000 |
Source: SEC EDGAR, Form 13F-HR, accession 0001819257-26-000005 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.